High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy

BJU International

Volumn 107, Issue 3, 2011, Pages 378-382

  Uchida, Toyoaki ^a   Shoji, Sunao ^a   Nakano, Mayura ^a   Hongo, Satoko ^a   Nitta, Masahiro ^b   Usui, Yukio ^b   Nagata, Yoshihiro ^a  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

HIFU; prostate cancer; radiation therapy; salvage therapy

Indexed keywords

GOLD 98; INDIUM 192; PROSTATE SPECIFIC ANTIGEN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EPIDIDYMITIS; EXTERNAL BEAM RADIOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH RISK PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; URETHRA FISTULA; URETHRA STRICTURE; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTONS; SALVAGE THERAPY; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 79251538666     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09518.x     Document Type: Article

References (21)

1. Foundation for Promotion of Cancer Research. National Cancer Center. CANCER STATISTICS IN JAPAN (2008). Available at:. Accessed 20 December 2009
2. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 1999; 281: 598-604
3. Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 2003; 57: 915-28
4. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007; 67: 327-33
5. Coen JJ, Zietman AL, Thakral H, Shipley W,. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastasis. J Clin Oncol 2002; 20: 3199-205
6. Chin JL, Izawa JL,. Treatment of radiation failure in prostate cancer. Can J Urol 2006; 13 (Suppl 2): 48-51
7. Nguyen PL, D'Amico AV, Lee AK, Suh WW,. Patient selection, cancer control, and complications after salvage local therapy for post radiation prostate specific antigen failure: A systematic review of the literature. Cancer 2007; 110: 1417-28
8. Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ,. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 2010; 105: 191-201
9. Pisters LL, Leibovici D, Blute M, et al. Locally recurrent prostate cancer after initial radiation therapy: A comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009; 182: 517-27
10. Eandi JA, Link BA, Nelson RA, et al. Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 2010; 183: 133-7
11. Gelet A, Chapelon JY, Poissonnier L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004; 63: 625-9
12. Murat FJ, Poissonnier L, Rabilloud M, et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 2009; 55: 640-7
13. Zacharakis E, Ahmed H-U, Ishaq A, et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int 2008; 102: 786-92
14. Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J,. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 2008; 7: 231-6
15. Uchida T, Shoji S, Nakano M, et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int J Urol 2009; 16: 881-6
16. Roach M III, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in patients with clinically localized prostate cancer. Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-74
17. National Cancer Institute. Common Toxicity Criteria (CTC), Version 2.0. April 30, 1999. Available at
18. D'Amico AV, Whittington R, Malkowicz B, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
19. Breeuwsma AJ, Pruim J, van den Bergh AC, et al. Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11)C-Choline Positron Emission Tomography. Int J Radiat Oncol Biol Phys 2010; 77: 160-4
20. Paparel A, Cronin AM, Savage C, Scardino PT, Eastham JA,. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 2009; 55: 404-10
21. Ahmed HU, Ishaq A, Zacharakis E, et al. Rectal fistula after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int 2009; 102: 321-23